GLP-1 Medications in 2026: What You Need to Know

---

If you've been researching GLP-1 medications for weight loss — or if you were already using them and suddenly lost access because of the FDA crackdown in early February 2026 — you've probably noticed how fast things are changing. Compounding pharmacies shutting down. Telehealth companies pulling back. Insurance plans dropping coverage. Oral versions launching. It's a lot.

I've been prescribing semaglutide and tirzepatide for years, and even I'm having to stay on top of regulatory changes weekly. So let me break down what's actually happening in the GLP-1 space right now, what your options are, and what you should be looking for in a provider if you're considering these medications.

This is the guide I wish someone had written for my patients six months ago.

---

What Are GLP-1 Medications?

Let's start with the basics. GLP-1 stands for glucagon-like peptide-1, which is a hormone your gut produces naturally after you eat. What it does is slow gastric emptying (food stays in your stomach longer), reduce appetite, improve insulin sensitivity, and signal your brain that you're full.

GLP-1 medications are synthetic versions of this hormone. They amplify the signal. The result: you eat less because you're genuinely less hungry, your blood sugar stabilizes, and your body shifts from storing fat to burning it.

The main GLP-1 medications you'll hear about are:

Semaglutide and tirzepatide are the most commonly prescribed for weight loss right now. Tirzepatide is technically a dual agonist (GLP-1 + GIP), which some studies suggest leads to slightly better weight loss outcomes, but both are effective.

These medications have been around for years for diabetes management, but the weight loss indication exploded in popularity around 2021-2023. By 2026, an estimated 15 million Americans are using GLP-1 medications, most of them for weight loss rather than diabetes.

---

The FDA Crackdown: What Happened and Why

Here's what changed in early February 2026, and why it matters for patients:

The Compounding Pharmacy Loophole (And Why It Closed)

For the past couple of years, compounding pharmacies were able to make their own versions of semaglutide and tirzepatide because these medications were on the FDA's drug shortage list. When a medication is in shortage, the FDA allows licensed compounding pharmacies (503A and 503B facilities) to produce compounded versions to meet patient demand.

This was a huge deal for cash-pay patients. Brand-name Wegovy or Zepbound costs $1,000-1,500 per month without insurance. Compounded versions from pharmacies? Often $200-400 per month. Telehealth companies like Hims, Ro, and dozens of others built entire business models around prescribing cheap compounded GLP-1s.

But in late 2025 and early 2026, the manufacturers (Novo Nordisk and Eli Lilly) ramped up production. The FDA removed semaglutide and tirzepatide from the shortage list. And once that happened, the legal cover for compounding pharmacies disappeared.

On February 6, 2026, the FDA announced plans to restrict the use of GLP-1 ingredients in non-approved compounded drugs. Within 24 hours, Hims — one of the largest telehealth GLP-1 providers — stopped offering compounded semaglutide. Other companies followed.

What This Means for Patients

If you were getting compounded semaglutide or tirzepatide from a telehealth service, that access is mostly gone now. Your options are:

Some compounding pharmacies are still operating, but the landscape is shifting fast. If you're working with a provider who's prescribing compounded GLP-1s, make sure they're staying current on FDA guidance and using pharmacies that are compliant.

The Oral GLP-1 Revolution

Here's the good news in all this chaos: oral GLP-1 medications are here, and they're changing the game.

Wegovy Pill (Oral Semaglutide)

In January 2026, Novo Nordisk launched an oral version of semaglutide (Wegovy pill). This is the same medication as the injectable version, just delivered in pill form. The cash price is significantly lower than the injection — roughly $149-299 per month depending on dosing and where you fill it.

The pill has to be taken daily on an empty stomach (30 minutes before eating or drinking anything), which is less convenient than a once-weekly injection. But for patients who hate needles or prefer oral medications, it's a legitimate option.

Initial patient response has been strong. The main barrier is remembering to take it correctly (empty stomach, 30-minute wait), but for patients who can build that routine, it works.

Orforglipron (Coming Soon)

Another oral GLP-1 medication called orforglipron is in late-stage trials and could get FDA approval in Q2 2026. This one is interesting because it's a non-peptide GLP-1 receptor agonist, which means it doesn't have the same absorption issues as oral semaglutide. If approved, it could be the most convenient GLP-1 option available.

What This Means

The oral options lower the barrier to entry significantly. A lot of patients were hesitant about injections. Now they don't have to be. And the pricing on oral semaglutide undercuts many of the compounded injection options that just disappeared.

If you're considering GLP-1 therapy in 2026, the oral route is worth discussing with your provider.

---

Insurance Coverage: Don't Count On It

Here's the reality: most insurance plans are not covering GLP-1 medications for weight loss, and the trend is moving in the wrong direction.

What's Happening with Coverage

The insurance industry's position is essentially this: GLP-1 medications for weight loss are elective, not medically necessary, and too expensive to cover broadly. Unless you have a diabetes diagnosis or significant obesity-related comorbidities (sleep apnea, cardiovascular disease), most plans won't touch it.

What This Means

If you're planning to use a GLP-1 medication for weight loss, plan to pay cash. That's the reality for the vast majority of patients. The good news is that oral semaglutide at $149-299/month and some remaining compounded options bring the cost down to a range where it's feasible for many people.

What to Look For in a GLP-1 Provider

This is the part that matters most, because not all GLP-1 prescribers are created equal. The telehealth mill approach — write a prescription, ship medication, collect monthly fee, never run labs, never address root causes — is not good medicine. It's a business model.

Here's what you should expect from a legitimate provider:

1. Comprehensive Metabolic Assessment Before Prescribing

Your provider should be running labs before starting you on a GLP-1 medication. At minimum, that includes:

Why does this matter? Because GLP-1 medications are tools, not solutions. If you have severe insulin resistance, hypothyroidism, chronic inflammation, or other metabolic dysfunction, the medication works better when you address those root causes alongside it. And if your provider doesn't know what your baseline metabolic state is, they can't track improvement or adjust treatment appropriately.

2. Monitoring and Dose Titration

GLP-1 medications are not one-size-fits-all. You start at a low dose and titrate up based on tolerance and response. A good provider will:

If your provider just prescribes a fixed dose and says "come back in six months," that's a red flag.

3. Root-Cause Investigation

This is where most providers stop, and it's the most important part. Your provider should be asking why you gained the weight in the first place. Is it insulin resistance? Hypothyroidism? Chronic inflammation? Gut health issues? Hormonal imbalance? Poor sleep and cortisol dysregulation?

GLP-1 medications suppress the symptoms (you lose weight because you eat less), but they don't fix the underlying dysfunction. If your provider isn't investigating root causes, the weight will likely come back when you stop the medication.

4. An Exit Strategy

You should not plan to be on GLP-1 medications forever. Some patients need them long-term, but for most, the goal should be to use the medication to create space — space to lose weight, reverse insulin resistance, build new habits, fix metabolic dysfunction — and then taper off.

A good provider will talk about this upfront. What's the plan for monitoring your progress? When do we reassess whether you still need the medication? What does tapering look like?

If your provider's plan is "stay on this indefinitely," ask why.

5. Expertise in Metabolic and Functional Medicine

Here's the thing: prescribing a GLP-1 medication is easy. Any provider can write the prescription. But managing the metabolic complexity that underlies weight gain? That requires deeper expertise.

Look for a provider who understands insulin resistance, thyroid optimization, gut health, inflammation, and hormone balance. Ideally, someone practicing functional or integrative medicine who's trained to address root causes, not just symptoms.

---

What About Side Effects?

GLP-1 medications are generally well-tolerated, but side effects are common, especially early on. The most frequent ones I see in my clinic:

Most of these are manageable. We adjust dosing, modify diet, add supportive interventions (fiber, hydration, probiotics). But if your provider isn't checking in regularly or doesn't have a plan for managing side effects, you're going to have a rough time.

The Bottom Line

GLP-1 medications in 2026 are effective, increasingly accessible (thanks to oral options), and navigating a chaotic regulatory landscape. If you're considering these medications, here's what you need to know:

If you approach GLP-1 therapy as part of a comprehensive metabolic strategy — addressing insulin resistance, thyroid function, gut health, inflammation, and lifestyle — these medications can be incredibly effective. You lose weight, you reverse metabolic dysfunction, and eventually you can come off the medication and maintain your results.

But if you treat it like a magic pill, you'll end up disappointed.

Rooted Health Clinic | Salado, Texas | Serving Central Texas